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Abstract
Background: Intensivists must provide enough analgesia and sedation to ensure dying patients
receive good palliative care. However, if it is perceived that too much is given, they risk prosecution
for committing euthanasia. The goal of this study is to develop consensus guidelines on analgesia
and sedation in dying intensive care unit patients that help distinguish palliative care from
euthanasia.
Methods:  Using the Delphi technique, panelists rated levels of agreement with statements
describing how analgesics and sedatives should be given to dying ICU patients and how palliative
care should be distinguished from euthanasia. Participants were drawn from 3 panels: 1) Canadian
Academic Adult Intensive Care Fellowship program directors and Intensive Care division chiefs (N
= 9); 2) Deputy chief provincial coroners (N = 5); 3) Validation panel of Intensivists attending the
Canadian Critical Care Trials Group meeting (N = 12).
Results: After three Delphi rounds, consensus was achieved on 16 statements encompassing the
role of palliative care in the intensive care unit, the management of pain and suffering, current areas
of controversy, and ways of improving palliative care in the ICU.
Conclusion: Consensus guidelines were developed to guide the administration of analgesics and
sedatives to dying ICU patients and to help distinguish palliative care from euthanasia.
Background
Intensivists are confronted with a difficult balance in pro-
viding analgesia and sedation for dying patients. If they
administer too little to control distress, they provide inad-
equate palliative care and patients suffer [1–7]. If they ad-
minister too much for life to continue, they may risk
prosecution for committing euthanasia [6,8–15]. With re-
cently increasing legal scrutiny, fear of prosecution may
continue to grow and perpetuate the undertreatment of
pain and suffering at the end of life [1–3], [7–16].
The alleviation of pain and suffering is crucial to the pro-
vision of quality end-of-life Care [17]. While the US Soci-
ety for Critical Care Medicine (SCCM) has published
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practice parameters[18] for the provision of analgesia and
sedation in critically ill ICU patients, no guidelines exist
for analgesic and sedative use in dying patients. In Cana-
da, the Chief Coroner of Ontario has defined palliative
care [19] to help coroners distinguish palliative care from
euthanasia; however, these guidelines are not specific to
the ICU and give no specific guidance on how to deter-
mine whether the doses given were commensurate with
patient distress.
The purpose of this study is to develop consensus guide-
lines on the use of analgesia and sedation in dying ICU
patients. Clear guidelines will help develop a standard of
care, diminish the risks of under-medication (inadequate
palliative care) and over-medication of pain and suffering
(possible euthanasia), and thereby improve the overall
quality of end-of-life care in the ICU.
Methods
Participants
Three panels were used in this study: The first Delphi pan-
el was formed by approaching the Adult and Pediatric
Critical Care fellowship program directors from all of the
Canadian academic centers; in academic centres without a
Critical Care fellowship program, the Intensive Care Divi-
sion Chief was approached. Fellowship program directors
and division chiefs were chosen since they represent an
easily identifiable group of Intensivists who usually act as
opinion leaders in Critical Care medicine in their academ-
ic centres. The continuing medical education literature
has shown the importance of opinion leaders in changing
current practice [20]. By using opinion leaders to develop
these guidelines, we hoped to increase the likelihood of
their eventual dissemination and use. Intensivists in non-
academic centres were excluded in order to ensure pan-
elists were "experts" in critical care medicine. In Canada,
non-academic ICUs frequently combine Intensive Care/
Coronary Care Units (ICU/CCU) and may be staffed by
physicians who have not been formally trained in Critical
Care Medicine. Out of a possible 27 panel members (13
adult, 14 pediatric), 19 (9 adult, 10 pediatric) agreed to
participate. Refusals to participate were predominantly at-
tributed to difficulty in fulfilling the time commitments
needed to participate in the study (n = 2 adult, n = 3 pedi-
atric); no reasons were provided in the remaining cases (n
= 2 adult, n = 1 pediatric). As the results from the second
Delphi round were analyzed, it became clear that a simple
consensus statement was not appropriate for both adult
and pediatric patients. This paper reports on the adult
consensus statement based on the responses of the 9 adult
Intensivists: 2 Anesthetists, 4 Respirologists, 2 Internists,
and 1 Surgeon; it included 7 men and 2 women.
The second Delphi panel was formed by approaching all
of the provincial Deputy Coroners/Medical Examiners. Of
a possible 14 panel members, 5 (all men) agreed to par-
ticipate. Reasons for refusal included lack of time (n = 5),
and lack of knowledge required to answer the initial Del-
phi questionnaire (n = 1); no reason was given in the re-
maining cases (n = 3). Coroners/medical examiners were
consulted to build understanding between the Intensivists
and coroners regarding what constitutes good palliative
care in the ICU setting and because upon review of a pa-
tient's death, coroners/medical examiners are expected to
be able to distinguish palliative care from euthanasia in all
clinical settings.
Because our goal was to develop consensus guidelines to
guide physicians ordering analgesia and sedation for dy-
ing patients – and thereby improve the quality of end-of-
life care they prescribe – ICU nurses and other allied
health professionals were not used in the development of
these guidelines.
The third panel was composed of a convenience sample of
the 12 academic Adult Intensivists who attended the End-
of-Life (EOL) Day of the national Canadian Critical Trials
Group (CCCTG) meeting in April 1999. These Intensiv-
ists, composing the validation panel, all have an interest
in researching the care received by dying patients in the
ICU. All 12 EOL Day attendees volunteered to participate.
Their responses were used to validate the consensus state-
ments obtained from the original two panels described
above. The validation panel was composed of 6 Internists,
and 6 Respirologists; it included 8 men and 4 women.
Consensus process
This study used the Delphi method to develop a consen-
sus statement on the appropriate use of analgesics and
sedatives in dying ICU patients. The Delphi method in-
volves several iterations ("rounds") of a questionnaire un-
til consensus is achieved within the chosen panel of
"experts" [21–27].
Panelists were provided with background information on
the problems of pain control in the ICU; problems in the
provision of quality end-of-life care; the importance of a
consensus statement on the use of analgesics and seda-
tives in dying ICU patients; and definitions of palliative
care, euthanasia and assisted suicide based on a MEDLINE
review of the literature from 1970–1999, prepared by the
authors. While definitions of euthanasia and assisted sui-
cide were provided, our goal was not to debate whether
these practices should be legalized and literature to sup-
port either side of this current debate was not presented to
panelists. Responses to the initial Delphi questionnaire
were based on this review of the literature and on the "ex-
pert" knowledge of the panel members.BMC Medical Ethics 2002, 3 http://www.biomedcentral.com/1472-6939/3/3
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In the first Delphi round, the Intensivist panel was asked
a series of 9 open-ended questions describing how analge-
sics and sedatives should be given to dying ICU patients
and how palliative care should be distinguished from eu-
thanasia (Table 1). The coroner/medical examiner panel
was asked 8 questions; their questionnaire was the same
as the Intensivists', but the first question was omitted be-
cause it required "expert" clinical knowledge that the cor-
oners would not possess. Responses to all Delphi rounds
were obtained via mail, fax and e-mail.
Since our goal was to develop Intensivist-based consensus
guidelines, the second Delphi round involved the Inten-
sivist panel only. The questions and concerns raised by the
coroner panel in the first Delphi round were inserted into
the appropriate section of the document that had been
generated by the Intensivist panel. Intensivist panelists
were then asked to comment on the document generated
in the first round, clarify any obscurities, and raise any
questions not adequately addressed. They were asked to
respond to new questions that were generated from either
the qualitative analysis of their previous responses, or
from the responses of the coroner panel in the first Delphi
round. They were also asked to rate their level of agree-
ment with each section and the overall document on a
Likert scale ranging from 1 (complete disagreement) to 7
(complete agreement).
The third Delphi round involved both adult Intensivist
and coroner panels. A summary of each section of the doc-
ument generated in the second round – which represented
the proposed consensus statement for that section – was
inserted as an italicized statement at the beginning of each
section. Panelists were then asked to rank their agreement
with each consensus statement on a Likert scale, and were
asked to identify modifications that would allow them to
agree completely with each statement. They were also
asked to rank their overall agreement with the document
and, again, identify changes that would allow them to
agree completely with the document. Median scores from
the second round were then presented to panelists in the
third Delphi round, enabling individual panel members
to compare their level of agreement with that of other
panelists. A fourth Delphi round was not required since
consensus was achieved in the third round.
The third panel (validation panel) was presented with the
final consensus statements obtained after the third Delphi
round. They were also asked to rate their agreement with
each statement on the same Likert scale. If they gave any
statement a score less than 5, they were again asked to
identify modifications that would allow them to agree
completely with that statement.
Data analysis
The responses of the Intensivists and coroner panels were
analyzed separately. Qualitative analysis was performed
by content analysis in each round [27]. Initially open cod-
ing was used to give conceptual labels to randomly select-
ed panelist responses [27]. These conceptual labels
generated the formation of categories (or sections)
[22,23,27]. Subsequently, the properties of each category
were delineated [27]. The responses of all panel members
carried equal weight [22,27].
Since a normal distribution could not be assumed, the
median score obtained from each section was used to de-
termine agreement among panelists. It was stipulated that
consensus was determined as 80% agreement (a median
Likert score of 5.6 on 7 point scale) within the initial 2
panels (Intensivists and coroners) [21,22]. It was decided
a priori that statements which did not achieve a Likert
score of 5.6 would be discarded.
Table 1: Initial Delphi Questionnaire ---- Intensivists
1. How should patients' pain and suffering be controlled at the end-of-life? (which drugs?, when?, how much?) Please justify your answer.a
2. What indications of the patient experiencing suffering and/or pain should be used to judge whether an appropriate amount of narcotic or sed-
ative has been used?
3. Is there a maximal dose of narcotic or sedative that you would recommend not be exceeded? Please justify your answer.
4. During withdrawal of care, would you recommend that narcotics and/or sedatives be given in incremental doses once suffering is evident or 
before it begins?
5. Is euthanasia (as defined in background information) acceptable or unacceptable?
6. a) Is terminal sedation (sedation to relieve pain until death occurs from the disease itself) euthanasia or acceptable practice? b) In terminal 
sedation, how should the drugs used to induce unconsciousness be incremented to palliate without causing death?
7. How can the intentions of the physicians administering sedatives/narcotics at the end-of-life be assessed (e.g. to palliate vs. to euthanize or to 
assist suicide)?
8. If the amount of narcotics and/or sedatives required to relieve pain and suffering at the end-of-life may forseeably cause hastening of death 
although the physician intends only to relieve pain and suffering, should this be considered assisted suicide or euthanasia?
9. How can palliative care be distinguished from euthanasia/assisted suicide in the ICU setting?
a This question was omitted from the coroners' initial questionnaire.BMC Medical Ethics 2002, 3 http://www.biomedcentral.com/1472-6939/3/3
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No modifications were made to the statements as a result
of the validation panel's comments. No statements were
discarded.
Research ethics
This study was approved by the University of Toronto's
Research Ethics Committee. Informed consent was ob-
tained from each panel member. Responses were kept
confidential and, after responses were received by the
principal investigator; all identifying information relating
to the individual panel member was removed.
Results
In the third round, consensus was obtained in both Del-
phi (Intensivist and coroner) panels on 16 statements.
These statements can be organized into 4 categories (ta-
bles 2,3,4,5). The first category (table 2) discusses 1) how
palliative care is different in the ICU than in other settings,
2) the role of palliative care in the ICU, and 3) the diffi-
culties in assessing pain and suffering that are specific to
the ICU.
The second category of consensus statements (table 3) de-
scribes the management of pain and suffering in the ICU.
These guidelines provide practical guidance on what clin-
ical factors to consider when selecting an initial starting
dose of analgesics and sedatives and how to judge wheth-
er an effective level of palliation was achieved. In view of
the high doses of drugs used in the ICU, the guidelines
emphasize that a maximum dose does not exist but rather,
the palliation of pain and suffering must be individual-
ized to each dying patient and drugs administered in ac-
cordance with clinical need.
The third category of consensus statements (table 4) fo-
cuses on areas of controversy in the current literature.
These statements discuss the role of palliation in persist-
ently vegetative patients, and describe how dying patients
paralyzed with neuromuscular blockers should be man-
aged. According to participants, terminal sedation repre-
sents another means of alleviating pain and suffering at
the end of life and is not euthanasia. The principle of dou-
ble effect whereby analgesics and sedatives may be admin-
istered to alleviate distress even though death may be
hastened by their administration was seen to be useful in
allowing physicians to achieve an effective level of analge-
sia. The physician's intent when administering these drugs
was seen as the distinguishing factor between palliative
care and euthanasia. Documentation of the reasons for
withholding/withdrawing life-sustaining treatments and
the ways pain and distress will be alleviated is important.
This not only ensures that the physician's intent in order-
ing and administering analgesics and sedatives is clear,
but improves the quality of end-of-life care within the ICU
by detailing a clear and comprehensive treatment plan.
Finally, the fourth category of consensus statements (Ta-
ble 5) discusses how palliative care in the ICU can be im-
proved in the future through research and ongoing
education of the staff. The guidelines explore the role of
Table 2: Palliative Care in the ICU
Palliative Care in the ICU
Good Intensive Care must seek to provide relief of pain and suffering for ALL Intensive Care Unit (ICU) patients, not solely for those for whom 
death is inevitable. The palliation of dying patients in the ICU is different from palliative care in other settings since the dying process tends to be 
more dramatic and the time from withholding/withdrawing active disease treatment to death is much shorter. Ensuring good palliative care in the 
ICU is crucial.
Goals of Palliative Care in the Intensive Care Unit
The goals of palliative care in the ICU are: 1) relief of pain, 2) relief of agitation and anxiety, 3) relief of dyspnea, 4) psychological and spiritual sup-
port of patient and family and, 5) provision of comfort by changing the technological ICU environment to a more comfortable, peaceful one. 
Patients' wishes, including those expressed by advance directives, must be respected by the medical team.
Difficulties in the Assessment of Pain and Suffering
Pain and suffering are different. The ability to assess a patient's pain and suffering is crucial, yet these skills are poorly taught, if taught at all. In the 
Intensive Care Unit, pain assessment is rendered even more difficult by: 1) communication problems imposed by the ICU environment, 2) the 
severity of illness and the presence of multisystem organ failure, 3) decreased level of consciousness of patients as a result of illness and drugs, 4) 
our own lack of knowledge/difficulty in interpretation of clinical signs, and, 5) the unreliability of clinical signs. Suffering, because of its even greater 
individual nature, is harder to assess. Since the assessment of suffering may not be easily amenable to teaching, what must be taught is respect for 
others' values; values through which individual suffering is perceived. Intensivists need to be aware of the abilities of their ICU staff in assessing and 
ensuring adequate relief of pain and suffering. Education, research and discussions with family members may be invaluable in improving the abilities 
of physicians and nurses to determine patient sufferingBMC Medical Ethics 2002, 3 http://www.biomedcentral.com/1472-6939/3/3
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emotional and psychological support of the ICU staff to
help them deal with the frequency of deaths in critically ill
patients. Such support will hopefully increase their abili-
ties to cope with the emotional and psychological stress in
caring for critically ill patients and allow them to provide
consistently good palliative care. The guidelines propose
increasing ties with Palliative Care Medicine. Traditionally
considered to be the polar opposite field in the spectrum
of care, Palliative Care Medicine may be invaluable in
helping to improve the quality of end-of-life care in the
ICU setting.
All guidelines achieved high degrees of consensus. The fi-
nal median Likert scores of all three panels are provided
in table 6.
Discussion
The goal of this study is to develop consensus guidelines
on analgesia and sedation that consider the unique chal-
lenges encountered when palliating dying ICU patients,
and help distinguish palliative care from euthanasia in the
ICU setting. The guidelines are not intended to argue for
or against the legalization of euthanasia. Our hope is that
the guidelines will decrease the confusion and anxiety re-
garding the use of opiates and sedatives at the end of life
and thereby improve the quality of care received by dying
patients. To meet this goal, we have divided the guidelines
into sections describing palliative care in the ICU setting,
management of pain and suffering, areas of controversy,
and ways of improving palliative care in the ICU.
A recent review of the literature by Ostermann et al. [28]
revealed the paucity of good randomized controlled trials
Table 3: Management of Pain and Suffering
Relief of Pain and Suffering
In order to relieve pain and suffering at the end-of-life, both pharmacological and non-pharmacological means should be used. Non-pharmacological 
interventions include ensuring the presence of family, friends and pastoral care (if desired), and, changing the technological ICU environment to a 
more private and peaceful one. Nursing interventions and accommodating patients' religious and cultural beliefs also play an important role in alle-
viating pain and suffering. Pharmacological interventions include any analgesics, sedatives or other adjuncts that will decrease discomfort. In general, 
narcotics are used for pain; benzodiazepines are used for agitation and anxiety. If the patient is experiencing pain and suffering, both analgesics and 
sedatives are used. This combination of drugs may provide better relief of pain and suffering at the end-of-life than either class of drug alone.
Initial Dosage
Most ICU patients require narcotics and sedatives in order to ease the pain and suffering associated with their critical illness. The amount of drugs 
needed varies on an individual basis. As in active disease treatment, palliative care MUST be individualized. Considerations affecting the initial dose 
of narcotics and sedatives in palliation include: 1) the patient's previous narcotic exposure since tolerance develops quickly, 2) age, 3) previous alco-
hol or drug use and/or abuse, 4) underlying illness, 5) underlying organ dysfunction 6) the patient's current level of consciousness/ sedation, 7) level 
of available psychological/spiritual support, and, 8) patients' wishes regarding sedation.
Titration of Analgesics and Sedatives
Once analgesics and sedatives are initiated, they are increased in response to 1) patient's request, 2) signs of respiratory distress, 3) physiological 
signs: unexplained tachycardia, hypertension, diaphoresis, 4) facial grimacing, tearing, vocalizations with movements, turns or other nursing care, 
and 5) restlessness. These clinical indicators, although crucial for graduated therapy, are imprecise. Ramsay or Likert scales, despite their limitations, 
may provide additional help in evaluating the patient's discomfort. The total amount of drugs required for any individual patient may far exceed any 
preconceived notions of usual, in reality non-existent, doses.
Does a Maximal Dose Exist?
No maximum dose of narcotics or sedatives exist. The goal of palliative care is to provide relief of pain and suffering and whatever the amount of 
drugs that accomplishes this goal is the amount that is needed for that individual patient. By refusing to define a maximal dose of analgesics or sed-
atives, our goal is to ensure that Intensivists will use the required dose for each patient. If a maximal dose is ever declared, some patients will be in 
pain and will be suffering at the end-of-life because of the Intensivist's fears of litigation if this maximal dose is exceeded. Therefore, the intent of the 
physician administering the drugs becomes important in distinguishing between palliative care and assisted death (euthanasia/assisted suicide).
Should Analgesics and Sedatives be Administered in Response to Signs and Symptoms of Pain and Suffering, or Before They Begin?
Support for both approaches exists among Intensivists on this panel. The treatment of signs and symptoms of pain and suffering is good palliative 
care. When appropriate doses of narcotics and sedatives are used and the intent of the physician is clear and well documented, pre-emptive dosing 
in anticipation of pain and suffering is not euthanasia nor assisted suicide but good palliative care.BMC Medical Ethics 2002, 3 http://www.biomedcentral.com/1472-6939/3/3
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on sedation in ICU patients. Research has revealed prob-
lems in alleviating pain even among skilled palliative care
providers [1–4,29,30] and there is no proof in the current
literature that Intensivists are better at relieving their dy-
ing patients' distress than other physicians [3]. Healthcare
providers withdrawing treatments from dying patients fre-
quently encounter apprehension and concern from sur-
viving family members about how their loved one's pain
and distress will be treated. In these situations of with-
drawal of life-sustaining treatment, both healthcare pro-
viders and family members hope for a speedy,
comfortable death in which pain and other distressing
symptoms are well controlled and the process of dying is
accomplished in peace with loved ones at the bedside
[17]. However, questions by family members often reveal
concern that their loved one's final moments will be filled
with suffering, or, alternatively, that drugs such as opiates
and benzodiazepines given by the healthcare team will
unduly hasten the dying process and/or kill their loved
one [1–3],[7–16,32,33].
Cases of euthanasia committed by healthcare providers
have occurred and receive widespread media attention [9–
15]. These highly publicized cases of euthanasia, restric-
tive prescribing legislation, and increased scrutiny by cor-
oners, licensing bodies, families and the public, lead
healthcare providers to under-treat the pain and symp-
toms of their dying patients [1–16,32,33]. Furthermore,
fears of being misunderstood – of having their intent to
palliate mistaken for an intent to kill – are currently being
exacerbated by debates/articles in the medical literature
[34–37]. The authors of these articles seek to promote the
legalization of euthanasia by misappropriating ethical
principles such as the Principle of Double Effect in order
to confuse their colleagues and diminish the fundamental
and very real differences between the practices of pallia-
tion and euthanasia [34–37]. An unintended conse-
Table 4: Current areas of Controversy
Special Situations
Neuromuscular blockers mask the clinical signs of pain and suffering delineated above. When possible, the withholding and withdrawal of life sup-
port should be started after their effects wear off in order to permit Intensivists to assess as accurately as possible the patient's pain and suffering 
and ensure good palliative care. If neuromuscular blockers were not in use, they should not be started in order to hide patient distress. The intent 
and justifications of Intensivists who fail to wait for neuromuscular blockers to wear off or who fail to reverse them must be carefully documented. 
Since patients in persistent vegetative states are deemed incapable of feeling pain or anxiety, sedatives and narcotics are usually not required during 
the withholding/withdrawal of life support. The family's perceptions of pain and suffering, however, may play a role in the use of narcotics and sed-
atives in these patients.
Terminal Sedation
Terminal sedation, defined in the literature as sedation with continuous IV narcotics and/or sedatives until the patient becomes unconscious and 
death ensues from the underlying illness, is palliative care, not euthanasia. Since terminal sedation may arguably make the detection of euthanasia/
assisted suicide more difficult, the intent of the Intensivist is crucial.
Intent
The intention of the Intensivist administering narcotics/sedatives to palliate dying patients can be assessed by careful documentation in the chart of: 
1) the patient's medical condition and reasons leading to the initiation of palliative care, 2) the goal, which is to relieve pain and suffering, 3) the way 
pain and suffering will be evaluated, and 4) the way in which drugs will be increased and why. Intensive care units should develop guidelines govern-
ing the process of withholding and withdrawal of life support and Intensivists should justify and document any need to deviate from the policy and 
the anticipated modifications. The administration of drugs without any palliative benefit, e.g. lethal doses of potassium chloride or neuromuscular 
blockers, suggests an intent to euthanize/assist in the suicide of an individual patient.
Principle of Double Effect
If the amount of narcotics/sedatives required to relieve pain and suffering at the end-of-life may foreseeably cause hastening of death, although the 
physician's intent is solely to relieve suffering, this should be considered palliative care.
Distinction between Palliative Care and Euthanasia
The intent of the physician administering narcotics and sedatives to the dying patient is the most crucial distinction between palliative care and 
assisted death (euthanasia/assisted suicide). In order to avoid any misinterpretations, Intensivists must clearly document, in the patient's chart, their 
intentions and justify their actions during the withholding/withdrawal process.BMC Medical Ethics 2002, 3 http://www.biomedcentral.com/1472-6939/3/3
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quence may be to increase the reluctance on the part of
health care providers to administer adequate analgesia
and sedation to dying patients.
The US Society for Critical Care Medicine practice param-
eters [18] and in Canada, the Ontario Chief Coroner's
memo on palliative care [19], have established practice
parameters on analgesia and sedation. Unlike our guide-
lines, the SCCM practice parameters [18] do not discuss
the use of opiates and sedatives in dying patients, while
the Ontario Chief Coroner's guidelines[19] do not relate
to the ICU. Brody et al. [38] also developed guidelines for
compassionate management in withdrawing intensive
life-sustaining treatments; however, these guidelines were
based on a literature review, did not use consensus meth-
odology or involve a national panel of Intensivists and
only represented the authors' opinions. Furthermore, Bro-
Table 5: Ways of Improving Palliative Care in the ICU
How Can We Improve our Abilities and our Consistency in Assessing and Treating Pain and Suffering?
Open discussions involving all members of the health care team and family, consulting and sharing when faced with difficult cases, improvements in 
education and research are needed. The development of a process to review our performance in palliative care within each ICU and national con-
sensus guidelines will also improve our skill in assessing pain and suffering and improve our abilities to relieve it at the end-of-life.
Support for the Intensive Care Unit Staff
The importance of psychological and emotional support for the ICU staff involved in palliating a dying patient is frequently overlooked. Developing 
a supportive working group, open communication and regular debriefings among members of the ICU team is crucial. The ICU social worker, pas-
toral care representative and, within the hospital, the departments of psychiatry and psychology may also be very helpful in enabling the ICU staff to 
continue to provide good palliative care.
Palliative Care Medicine Consultation
Currently a formal Palliative Care consult is rarely requested during the withholding and withdrawal of life support. If the expertise exists within the 
ICU, such a consult is not required. A Palliative Care Medicine consultation could be useful to: 1) treat symptoms that are difficult to control, 2) 
treat difficult pain syndromes, 3) provide guidance on the use of adjuncts that we, as Intensivists, use infrequently in the dying process, 4) provide 
guidance when using analgesics/sedatives infrequently administered, 5) help when significant psychological issues within the family or health care 
team are evident, 6) provide guidance in ICUs where the practices of withholding/withdrawal of care is infrequent, 7) help ease the patient's trans-
fer to the ward if he/she survives the withholding/withdrawal process, and 8) provide ongoing help in relieving pain and suffering when death is pro-
tracted.
Table 6: Median Likert Agreement Scores ----- Final Delphi Round
Intensivist Coroner Validation
Palliative Care in ICU: 7 (5 – 7)a 7 (5 – 7) 6 (3 – 7)
Goals of Palliative Care: 7 (6 – 7) 6 (5 – 7) 7 (4 – 7)
Difficulties in Assessment: 7 (6 – 7) 7 (4 – 7) 6 (5 – 7)
Relief of Pain & Suffering: 7 (4 – 7) 7 (6 – 7) 7 (6 – 7)
Initial Dose: 7 (4 – 7) 7 (6 – 7) 6.25 (5 – 7)
Titration: 7 (6 – 7) 7 (5 – 7) 5.25 (4 – 7)
Maximal Dose: 7 (2 – 7) 7 (5 – 7) 6.5 (4 – 7)
Timing of Administration: 7 (6 – 7) 7 (5 – 7) 6 (4 – 7)
Special Situations: 7 (3 – 7) 7 (5 – 7) 6 (2 – 7)
Terminal Sedation: 7 (4 – 7) 7 (4 – 7) 6 (5 – 7)
Intent: 7 (4 – 7) 7 (6 – 7) 6 (3 – 7)
Double Effect: 7 (6 – 7) 7 7 (5 – 7)
Palliative Care vs. Euthanasia: 7 (4 – 7) 7 6 (4 – 7)
Improvement of Palliation: 7 (5 – 7) 6 (5 – 7) 6 (5 – 7)
Support for Staff: 7 (5 – 7) 7 (5 – 7) 6 (5 – 7)
Palliative Care Consult: 7 (2 – 7) 7 (5 – 7) 5.5 (3 – 7)
a values in () indicate range of Likert scoresBMC Medical Ethics 2002, 3 http://www.biomedcentral.com/1472-6939/3/3
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dy et al. [38] do not attempt to address how palliative care
can be distinguished from euthanasia in the ICU.
To our knowledge, our consensus guidelines on analgesia
and sedation in dying ICU patients are the first of their
kind developed using consensus methods and involving
coroners. The use of consensus methodology and the par-
ticipation of coroners will hopefully serve to clarify the ar-
eas of controversy, their nature and help us resolve these
dilemmas in the future. As well, participation by coroners
will hopefully result in increased understanding of the dif-
ficulties faced both by those caring for the dying and for
those asked to review the care received – for it is only
through open dialogue that we can ever hope overcome
any doubts about intent – to palliate or to kill – and there-
by improve the quality of end-of-life care.
This study has three main limitations. First, our guidelines
use a small group of expert Intensivists and Coroners to
focus attention on how pain and suffering ought to be pal-
liated at the end of life. While our panel sizes were small,
saturation of responses occurred in each Delphi round, a
sign of credibility (internal validity). Although we at-
tempted to validate our consensus statements by using an
independent panel of Intensivists, this panel was also
small. While the validation panel was a convenience sam-
ple, panelists were representative of Intensivists across the
country and agreed with all of the developed consensus
statements, a sign of transferability (external validity).
Second, our consensus guidelines are physician-based.
They represent an initial attempt to improve the quality of
end-of-life care in the ICU by describing best practice in
regards to the administration of analgesics and sedatives
to dying patients. In order to improve the overall quality
of end-of-life care in the ICU, these consensus guidelines
need to be incorporated into an overall program to edu-
cate the ICU staff in caring for dying patients. These guide-
lines can then be discussed and modified as needed by
other members of the ICU team
Third, our consensus guidelines are developed from a pro-
fessional and not a patient's perspective. Intensivists' as-
sumptions on how to best treat pain and suffering at the
end of life may differ markedly from patients' and fami-
lies' lived experiences. More research is needed to explore
the patient's and family's perspective on how palliative
care can be improved in the ICU.
Conclusion
We have developed a set of guidelines that can be used by
critical care societies, training programs, and coroners
alike to guide the provision of analgesia and sedation in
the ICU. Application of our guidelines should minimize
the twin risks of under-treatment (and its resultant pain
and suffering) and over-treatment (and its resultant risk of
prosecution for euthanasia) for dying patients in the ICU.
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